Log in to your account:
Amgen (AMGN) patent on blockbuster Repatha drug invalid, judge rules - Bloomberg (REGN)
August 28, 2019 3:05 PM
Amgen (NASDAQ: AMGN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)